Consumer medicine information

Solicare 10 mg Tablets

Solifenacin succinate

BRAND INFORMATION

Brand name

Solicare

Active ingredient

Solifenacin succinate

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Solicare 10 mg Tablets.

What is in this leaflet


Read this leaflet carefully before you start taking this medicine.
This leaflet answers some common questions about SOLICARE.
It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the risks of you taking SOLICARE against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, talk to your doctor or pharmacist.
Keep this leaflet with your medicine.
You may need to read it again.

What SOLICARE is used for


SOLICARE is used to treat the symptoms of overactive bladder. These symptoms include needing to rush to the toilet to urinate without warning, needing to urinate frequently, or wetting yourself because you did not get to the toilet in time.
SOLICARE belongs to a group of medicines called anticholinergic medicines. It works by acting on specialised cells to reduce the activity of your bladder and help you control your bladder.
Your doctor may have prescribed SOLICARE for another reason. Ask your doctor if you have any questions about why SOLICARE has been prescribed for you.
SOLICARE is available only with a doctor's prescription.
There is no evidence that SOLICARE is addictive.

Before you take SOLICARE

When you must not take it


Do NOT take SOLICARE if you are allergic to medicines containing solifenacin or any of the ingredients listed at the end of this leaflet.
Some of the symptoms of an allergic reaction may include skin rash, itching or hives, swelling of the face, lips or tongue which may cause difficulty in swallowing or breathing, wheezing or shortness of breath.
Do not take SOLICARE if you:
  • suffer from urinary retention (inability to urinate or empty your bladder completely)
  • are undergoing haemodialysis
  • have severe kidney disease or moderate liver disease and are also taking medicines that can decrease the removal of SOLICARE from the body (see Taking other medicines)
  • have severe liver disease
  • have uncontrolled glaucoma (high pressure in the eyes, with gradual loss of eye sight)
  • have myasthenia gravis, a disease of the muscles causing drooping eyelids, double vision, difficulty in speaking or swallowing and sometimes muscle weakness in the arms or legs
  • have a blocked gastro-intestinal tract or other gastro-intestinal disorders such as ulcerative colitis or toxic megacolon.

Do not take SOLICARE if the expiry date (Exp.) printed on the pack has passed.
Do not take SOLICARE if the packaging is torn or shows signs of tampering.

Before you start to take it


Tell your doctor if you are allergic to any other medicines, foods, dyes or preservatives.
Do not give SOLICARE to children.
Tell your doctor if you are pregnant.
SOLICARE may affect your developing baby if you take it during pregnancy. Your doctor will decide if you should take it.
Do not take SOLICARE if you are breastfeeding.
Tell your doctor if you have, or have had, any medical conditions, especially the following:
  • low potassium levels or a family history of heart rhythm problems. SOLICARE may have an effect on the electro-cardiogram (ECG - a heart tracing) and may add to the effect of other medicines on the ECG. You should advise your doctor of any other medicines you are currently taking, particularly those affecting the heart rhythm. Your doctor may wish to perform an ECG if you have any risks of having an abnormal heart rhythm.
  • blockage to your bladder that causes difficulty urinating
  • obstruction of the digestive system (constipation)
  • glaucoma (high pressure in the eyes, with gradual loss of eye sight)
  • hiatus hernia or gastric reflux or are currently being treated with some medicines (such as bisphosphonates) which may make your reflux worse
  • autonomic neuropathy, a nerve problem which sometimes occurs with diabetes and can lead to diarrhoea, impotence or low blood pressure
  • severe kidney disease
  • moderate liver disease.

If you have not told your doctor about any of the above, tell him/ her before you start taking SOLICARE.

Taking other medicines


Tell your doctor if you are taking any other medicines, including any that you buy without a prescription from a pharmacy, supermarket or health food shop.
Some medicines may be affected by SOLICARE, or may affect how well it works.
Some medicines can slow down the removal of SOLICARE from the body. If you are taking any of the following, 5 mg a day is the maximum recommended dosage:
  • some antifungal medicines such as ketoconazole, itraconazole
  • ritonavir and nelfinavir, medicines to treat HIV infection.

If you are taking any of the above medicines and you also have severe kidney disease or moderate liver disease, you should not take SOLICARE.
If you are not sure whether you are taking any of these medicines, check with your doctor or pharmacist.
Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking SOLICARE.

How to take SOLICARE

How much to take


The usual dose is 5 to 10 mg of SOLICARE once a day. Your doctor will decide the most suitable dose for you.
Talk to your doctor or pharmacist if you feel that the effect of SOLICARE is too strong or too weak.
Follow all directions given to you by your doctor and pharmacist carefully.

How to take SOLICARE


Try and take SOLICARE at the same time each day. SOLICARE is taken by mouth. It can be taken with or without food.
Swallow the tablets whole with a glass of water.
Do not crush or chew the tablets.
If you crush or chew SOLICARE tablets, they may not work as well.

If you forget to take SOLICARE


If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.
Otherwise, take the missed dose as soon as you remember, and then go back to taking your tablets as you would normally.
Do not take a double dose to make up for the dose you missed.
If you are not sure what to do, ask your doctor or pharmacist.

How long to take SOLICARE for


To properly control your condition, SOLICARE must be taken every day.
Keep taking SOLICARE for as long as your doctor recommends.

If you take too much (overdose)


Immediately telephone your doctor, or the Poisons Information Centre (telephone 13 11 26) if you think you or anyone else may have taken too much SOLICARE. Do this even if there are no signs of discomfort or poisoning.

While you are taking SOLICARE

Things you must do


Before starting any new medicine, tell your doctor or pharmacist that you are taking SOLICARE.
Tell all the doctors, dentists and pharmacists who are treating you that you are taking SOLICARE.
If you become pregnant while taking SOLICARE, tell your doctor.
Visit your doctor regularly so they can check on your progress.

Things you must not do


Do not stop taking SOLICARE, or lower the dose, without checking with your doctor.
Do not use SOLICARE to treat any other conditions unless your doctor tells you to.
Do not give SOLICARE to anyone else, even if they have the same condition as you.

Things to be careful of


Be careful driving or operating machinery until you know how SOLICARE affects you.
SOLICARE can sometimes cause blurred vision and less frequently drowsiness and fatigue.
Do not drive or operate machinery if you suffer from any of these side effects.

Side effects


Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking SOLICARE.
Like all other medicines, SOLICARE may have unwanted side effects in some people. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
Ask your doctor or pharmacist to answer any questions you may have.
Stop taking SOLICARE and tell your doctor as soon as possible if you experience:

  • allergic reactions including swelling of the face, lips, throat or tongue, difficulty breathing

Tell your doctor as soon as possible if you notice any of the following:
  • chest pain or tightness
  • swelling of the feet or legs
  • changes in electrical activity of the heart (ECG), irregular heartbeat (Torsade de Points)

Tell your doctor if you notice any of the following and they worry you:
  • dry mouth
  • nausea, vomiting
  • constipation
  • indigestion
  • heartburn (dyspepsia)
  • stomach discomfort
  • urinary tract infection, bladder pain
  • difficulty passing urine, inability to empty the bladder
  • urgent need to urinate
  • blurred vision
  • inability to empty the bladder
  • dry eyes
  • tiredness
  • muscle weakness
  • accumulation of fluid (swelling) in the lower limbs (oedema)
  • dizziness
  • sore / dry throat
  • cough
  • headache
  • sleepiness
  • hallucination
  • confusion
  • depression
  • fast heartbeat
  • palpitations
  • skin reactions such as rash, itching or hives.

Other side effects not listed above may also occur in some patients. Tell your doctor if you notice anything that is making you feel unwell.
Some of these side effects (for example, changes in electrical activity of the heart or liver function) can only be found when your doctor does tests from time to time to check your progress.

After using SOLICARE

Storage


Keep SOLICARE where children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.
Keep your tablets in a cool dry place where the temperature stays below 25°C.
Do not store SOLICARE or any other medicine in the bathroom or near a sink.
Do not leave SOLICARE in the car or on window sills.
Heat and dampness can destroy some medicines.

Disposal


If your doctor tells you to stop taking SOLICARE, or your tablets have passed their expiry date, ask your pharmacist what to do with any that are left over.

Product description

What it looks like


SOLICARE comes in two strengths of tablets:
  • SOLICARE 5 mg tablets are yellow coloured, round, biconvex, film coated tablets with ‘SOL’ debossed on one side and ‘5’ on the other side.
  • SOLICARE 10 mg tablets are pink coloured, round, biconvex, film coated tablets with ‘SOL’ debossed on one side and ‘10’ on the other side.

Available in blister packs of 10 and 30 30 tablets.

Ingredients


The active ingredient in SOLICARE is solifenacin succinate
  • each SOLICARE 5 mg tablet contains 5 mg solifenacin succinate
  • each SOLICARE 10 mg tablet contains 10 mg solifenacin succinate

The tablets also contain:
  • maize starch
  • lactose
  • hypromellose
  • magnesium stearate
  • colloidal anhydrous silica
  • OPADRY complete film coating system 03F12967 YELLOW (ARTG 11591) (5 mg tablets only)
  • OPADRY complete film coating system 03F14895 PINK (ARTG 11590) (10 mg tablets only)

Sponsor:


Arrotex Pharmaceuticals Pty Ltd
15-17 Chapel Street
Cremorne VIC 3121
This leaflet was prepared in: January 2024
Australian Registration Numbers:
  • SOLICARE 5 mg tablets AUST R 248408
  • SOLICARE 10 mg tablets AUST R 248407

BRAND INFORMATION

Brand name

Solicare

Active ingredient

Solifenacin succinate

Schedule

S4

 

1 Name of Medicine

Solifenacin succinate.

2 Qualitative and Quantitative Composition

Solicare 5 mg film-coated tablet: each tablet contains 5 mg solifenacin succinate, corresponding to 3.8 mg solifenacin.
Solicare 10 mg film-coated tablet: each tablet contains 10 mg solifenacin succinate, corresponding to 7.5 mg solifenacin.
List of excipients with known effect. Contains sugars as lactose.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

5 mg film-coated tablet. Each 5 mg tablet is yellow coloured, round, biconvex, film coated tablets with 'SOL' debossed on one side and '5' on the other side.
10 mg film-coated tablet. Each 10 mg tablet is pink coloured, round, biconvex, film coated tablets with 'SOL' debossed on one side and '10' on the other side.

4 Clinical Particulars

4.9 Overdose

Overdosage with solifenacin succinate can potentially result in severe anticholinergic effects (headache, dry mouth, dizziness, drowsiness and blurred vision) and should be treated accordingly. The highest dose of solifenacin succinate accidentally given to a single patient was 280 mg in a 5 hour period, resulting in mental status changes not requiring hospitalization.
Overdosage with solifenacin succinate may prolong the QTc interval, therefore, in the event of overdosage, ECG monitoring is recommended and standard supportive measures for managing QT prolongation should be adopted.
Treatment of overdosage. No cases of acute overdosage have been reported. In the event of an overdose with solifenacin succinate, treat with activated charcoal.
For information on the management of overdose, contact the Poisons Information Centre on 131126 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. Solifenacin was not mutagenic in the in vitro Salmonella typhimurium or Escherichia coli microbial mutagenicity test or chromosomal aberration test in human peripheral blood lymphocytes, with or without metabolic activation, or in the in vivo micronucleus test in rats.
Carcinogenicity. No significant increase in tumors was found following the administration of solifenacin to male and female mice for 104 weeks up to 5 and 9 times exposure at the maximum recommended human dose (MRHD), respectively, and male and female rats for 104 weeks at doses that resulted in < 1 times exposure at the MRHD.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSSOLIFE.gif Chemical Name: (3R)-1-azabicyclo[2.2.2]octan-3-yl(1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate hydrogen butanedioate.
Molecular Formula: C23H26N2O2.C4H6O4.
Molecular Weight: 480.55.
CAS number. 242478-38-2.

7 Medicine Schedule (Poisons Standard)

S4 - Prescription Only Medicine.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/SOLICAST.gif